Myeloid Cells: Functional Heterogeneity with Therapeutic Promise 

Published in Immunology

Myeloid Cells: Functional Heterogeneity with Therapeutic Promise 
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

Title: Myeloid Cells: Functional Heterogeneity with Therapeutic Promise 

Date: February 23-26, 2026 
Location: Keystone Resort, Keystone, CO, United States 

Important Deadlines 

Early Registration Deadline: December 30, 2025 

Scholarship Deadline: October 29, 2025 

Short Talk Abstract Deadline: October 29, 2025 

Poster Abstract Deadline: February 3, 2026 

Scientific Organizers: Charlotte L. Scott, Shalin H. Naik, and Thomas Fabre 

Keynote Speaker: Shannon J Turley, Genentech, Inc.

This Keystone Symposia Myeloid Cells meeting will bring together leaders from academia and industry to discuss the latest insights into myeloid cell heterogeneity and how these cells can be harnessed for therapeutic benefit. Although myeloid cells hold tremendous therapeutic promise, this potential has yet to be fully realized. Unlike previous meetings that focused primarily on academic advances, this program will also highlight cutting-edge industry approaches and translational applications, fostering collaboration across sectors to accelerate therapeutic innovation. 

A key theme will be translating recent discoveries into actionable therapies, including how single-cell RNA-seq studies have revealed both unique and conserved myeloid populations across tissues and diseases. Discussions will address pivotal questions for the field: How can these insights be leveraged therapeutically? What emerging technologies will drive future breakthroughs? 

The meeting will also provide trainees with valuable perspectives on how science is conducted in both academic and industrial settings, offering insight into the process of therapy discovery and development. 

Joint Meeting with “Hematopoiesis: From Stem Cells to Function and Disease” 
Held in conjunction with the Hematopoiesis meeting, this joint event will provide an integrated view of how hematopoietic stem cells and myeloid lineages intersect in health and disease. Shared sessions and networking opportunities will enrich discussions and catalyze new collaborations across both fields. 

View the program 

Join Options 

Attend in person or catch sessions on demand after the conference. 

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in